SBPC is now collaborating with a full-service immunohistochemistry and molecular pathology laboratory in the San Francisco Bay Area in order to provide more extensive services to our clients who want a second opinion.
We also now accept most major insurance as well as credit cards for payment on second opinions.
Contact us at info@breastpathologyconsults.com for more information.
Nine of my colleagues and I who specialize in breast pathology from the US and Australia reviewed 21 difficult consult cases which were sent in for second opinion with a question of cellular fibroadenoma vs. phyllodes tumor. Our abstract was accepted for presentation at the USCAP’s 100th annual meeting in San Antonio, TX. We attempt [...]
Question: I had a stereotactic biopsy on 11/23/10 for pleomorphic clustered microcalcifications. These were identified on additional view mammogram. US also noted at least 15 small simple cysts, a 7mm benign appearing solid mass such as fibroadenoma or fibrocystic mastopathy and no masses in the region of the pleomorphic clustered microcalcifications. My Dr. [...]
Our book chapter on how women are treated disparately following a core needle breast biopsy of a “high risk” lesion has now been published in the current issue of Radiologic Clinics of North America. My colleague from Harvard Medical School and I want women to know that the current data in the breast cancer literature [...]
There is a recent study published in the September 23 issue of Breast Cancer Research that looked at changes in prognostic markers (estrogen/progesterone receptor and HER2/neu) between primary breast cancers and metastatic lesions. If you click on the Breast Cancer Research link it will provide you with the abstract. The full article is temporarily free from [...]
San Antonio, March 3, 2011:
“Practical Approaches to Challenging Breast Lesions in Everyday Practice”
Las Vegas, March 14-15, 2011:
“The Importance of Second Opinions in Breast Pathology”
“Breast Pathology for Non-Pathologists”
Chicago, May 3-4, 2011:
“Controversies on High Risk Lesions at Core Biopsy: Radiology and Pathology Perspectives”
Question: My 75 y/o mother who was sent to an oncologist due to a bone scan that showed a hot spot on the right rib. A bone marrow biopsy/aspir was done and she was diagnosed with breast cancer with mets to the spine-results were ER/PR +. Mammograms, cat scans, Petscans were neg. She [...]
If you haven’t seen this recent article from the New York Times it’s worth a read.
I have posted before about the importance of getting your breast biopsy diagnosed from a pathologist who specializes in breast pathology. This article points out how subtle the distinction can be between atypical ductal hyperplasia and low grade ductal carcinoma [...]
Question: I recently had a breast biopsy with invasive ductal carcinoma, grade 3 and ductal carcinoma in situ. My report said “the carcinoma is estrogen and progesterone receptor negative (<5%) and negative for her2/neu over-expression (1+).” I read online that sometimes even less than 5% could still be positive for the estrogen receptor. [...]
I wrote an article a while back called “What Your Core Needle Biopsy Diagnosis Means” to help patients understand why sometimes even a “benign” diagnosis may require a surgical excision. While writing that article, I spoke to many of my colleagues in breast pathology and breast imaging and found out that there is a marked [...]